Health News Releases

November 04, 08:39

New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54348492&newsitemid=20251030478402&lan=en-US&anchor=TSE%3A4

November 03, 11:44

Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary

Samsung Epis Holdings Co., Ltd. today announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Sams

October 31, 10:40

Novotech Maps Global Growth in Radiopharmaceutical Trials

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, today released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research a

October 31, 10:15

Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China

October 30, 16:51

Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54345580&newsitemid=20251029831616&lan=en-US&anc

October 30, 16:30

SS&C Introduces AI Agents to Simplify Financial Services and Healthcare Operations

SS&C Technologies Holdings, Inc. (https://www.ssctech.com/?utm_campaign=SSC2025-Enterprise-Press-Release-1025&utm_medium=pressrelease&utm_source=prnews&utm_content=SSNC-AI-Agents) (Nasdaq: SSNC) today

October 30, 16:20

Swiss Rockets Announces Strategic Exclusive License Acquisition of Cutting-Edge Sequencing Technology from MGI Tech and Complete Genomics

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual,

October 30, 13:52

ONEWAYLAB Expands Global Presence with Cutting-Edge Beauty Tech at Beautyworld Middle East 2025

ONEWAYLAB Co., Ltd. announced its participation in Beautyworld Middle East 2025, one of the world’s leading exhibitions for the beauty and wellness industries, held in Dubai. Certified as an offici

October 30, 09:00

Ferring Pharmaceuticals to Explore Strategic Options for Rebyota®

As part of our ongoing transformation to sharpen our focus, we have decided to explore strategic options for Rebyota® (faecal microbiota, live - jslm). To date, more than five thousand patients suffer

October 29, 10:55

SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia

SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green La

October 28, 15:30

Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy - Technology Transferred from Japan

Significantly extended survival and improved quality of life (QoL) for cancer patients achieved through autologous cell-based AIET immunotherapy (https://www.immunotreatment.org/), utilizing patients'

October 27, 08:00

NURI SCIENCE Expands into Latin American Market through Exclusive Partnership in Paraguay

NURI SCIENCE Inc., a biotechnology company specializing in livestock reproduction technology, has signed an exclusive distribution agreement with Buenos Negocios S.A., a leading agricultural and lives

October 26, 11:15

Berry Consultants Releases FACTS 8 Clinical Trial Simulator

Berry Consultants, LLC announced the release of FACTS 8 (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.berryconsultants.com%2Fsoftware%2Fchangelog&esheet=54344231&newsitemid=20

October 24, 15:50

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for “Bubble Baby Disease”

AGC Biologics, your friendly CDMO expert, today announced an agreement with Rarity PBC to provide comprehensive development and Good Manufacturing Practice (GMP) manufacturing for Rarity’s gene therap

October 23, 17:35

BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54341613&newsitemid=20251020512177&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

October 23, 16:58

Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commerci

October 23, 15:00

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 p

October 23, 14:10

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital

Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today a

October 23, 11:40

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members

HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54343102&newsitemid=20251022130560&lan=en-US&anchor=HistoSonics&index=1&md5=40fd847d883559ad8d0

October 22, 17:15

Rigaku opens Rigaku Technology Center Taiwan

Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) hereby announces the establishment of Rigaku Technology Taiwan Co., Ltd. (hereinafter “RTTW”), a ne

October 22, 15:55

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and ph

October 22, 15:15

Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation

Baszucki Group is proud to announce the six recipients of the first-ever Metabolic Psychiatry Scholar Award (https://baszuckigroup.com/metabolic-psychiatry-scholar-award/), a new initiative that suppo

October 22, 14:50

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54343084&newsitemid=20251021006409&lan=en-US&anchor=TSE%3A4502%2FNYSE%

October 22, 11:10

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and le

October 21, 09:45

Samsung Bioepis And Phrontline Announce a Global Strategic Partnership to Advance Best-in-Class Antibody-Drug Conjugate Therapeutics for Solid Tumors

Samsung Bioepis Co., Ltd. and Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that the companies have entere

News by Region

News by Industry